{{Rsnum
|rsid=9284813
|Chromosome=3
|position=87103019
|Orientation=plus
|GMAF=0.2429
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LINC00506
|Gene_s=LINC00506
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 75.2 | 22.1 | 2.7
| HCB | 47.4 | 43.8 | 8.8
| JPT | 61.9 | 33.6 | 4.4
| YRI | 28.6 | 46.9 | 24.5
| ASW | 40.4 | 38.6 | 21.1
| CHB | 47.4 | 43.8 | 8.8
| CHD | 53.2 | 36.7 | 10.1
| GIH | 51.5 | 46.5 | 2.0
| LWK | 24.5 | 53.6 | 21.8
| MEX | 81.0 | 19.0 | 0.0
| MKK | 17.9 | 46.2 | 35.9
| TSI | 78.4 | 20.6 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20676098
|Trait=None
|Title=Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
|RiskAllele=
|Pval=5E-9
|OR=None
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}